Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / GRANATA BIO Corp

GRANATA BIO Corp

Stage unknownDuxbury, MAgranata.bioBiotechnology
Facts
Year of incorporation
2020sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Dec 19, 2024
    Form D equity offering · $13.8M (form d sold) · 3 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “GRANATA BIO Corp filed Form D: $13,765,000 sold of $14,999,999, Biotechnology
Investors on record
1 edges
People
3 officers, 2 directors
Timeline
1
  1. Dec 31, 2024
    GRANATA BIO Corp filed Form D: $13,765,000 sold of $14,999,999, Biotechnology
Evidence
17 observations
Every observation on this company